I don't think P was anticipated to be overly successful.

New Post Public Reply Private Reply Replies (1) Message Board
incubus TheDane #23070
I don't think P was anticipated to be overly successful. Actually, I would take P over the other products on the market from the results we've seen. I thought the P test was very successful. Remember, they started at 50 mg. 200 mg results were outstanding.

The Judge dismissing the case is one of the biggest items on my radar for a long time. It's what got us here and can remove that.

B-ASSSI 3, what's taking so long? Grant funding, lab availability my guess.

B-OM, interim results needed.

The results for Kevetrin have taken a long time but think this is normal plus the researchers extended the interest in using it now, unapproved, and don't really know if they have stopped using it. That's a pretty strong positive. BK said medical journal articles can take up to 2 years. Who really knows.

The neighborhood article, yards are already planted, blooming so why have it now. One has to take the photos at prime time for the article then it has to be written. Do it in spring to have the best viewership.

The consistent selling can very well be Aspire if they are getting .50 profit on the every dollar. That goes into the bank for research. Add the shorts who will play this until there is motivation to cover and go long.

The economy is sucking here and around the world. Today, watching Bloomberg Surveillance, they were talking about hedge funds crashing and people taking their money out and it's industry wide. Our guy at Morgan Stanley is their top guy in the country and he's sucking rocks right now.

But the economy will come back, stock will move higher, CTIX will continue to test product through to FDA approval and it could easily be P as one of their first. Don't see any failures yet with any product.

I'm sure Leo isn't in his swim suit but is playing in an ocean of sharks.

Today's PR follow-up was in response to those who 'didn't get it' with their initial report which was probably hurried due to the long week-end that started today for many. Today's information at the time of the initial report would have been better.

We have to remember that the overwhelming majority of people do not read chat rooms to make decisions on what stock to purchase. Manipulators are more suited for that arena. Not suggesting you or me of course but track records are the best way to make stock decisions and most people go for the established winners for expected outcomes.

Leo is building a good if not great company and I have the time to let him do it and will do so. I wouldn't be surprised if we don't have a partnership for P within a reasonable time, sooner than you think. The p3 study will have to be approved, locations selected and trial run. The trial is very fast. He could have that partner sooner than we think. Less money now or much more later. The companies with mega dollars might want to risk theirs now vs waiting until it's much more expensive. jmo

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hudsonville's Leadership Shift Eyes the Future

Updated Category News Views 168

Hudsonville's New Chapter: Enter CJ Ellens When a firm as storied as Hudsonville Ice Cream elects a new captain at the helm, folks sit up and take notice. CJ Ellens, already well-embedded in the fabric of Hudsonville, is set to steer the ship starting January 1, 2027. This isn't just a revolving door of C-suites, but more like a passing of the torch to someone bred in the...

Continue Reading
Young Talent Tackles IVF & Air Pollution Research

Updated Category News Views 81

Rookie Researcher: Jeffrey's Bold Leap at ASRM 2026 Teenagers typically have their heads buried in textbooks, but Jeffrey Huang's got his eyes set on something bigger. This high school junior from Taipei American School leaped onto the international stage at the American Society for Reproductive Medicine (ASRM) 2026, carrying a scientific study centred on a critical...

Continue Reading
LG Energy Solution's Q3 2026: Power Moves in ESS Expansion

Updated Category News Views 103

LG's Strategic Battery Play You know it's serious when a company pushes into new territories with gusto. LG Energy Solution isn’t tiptoeing with their recent financials—Q3 2026 showed 'em raking in KRW 9.6 trillion in revenue. That's a mighty 27.6% uptick from the previous quarter, no small potatoes by any stretch, especially when their operating profit stands solid...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 57

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
AAR's $1.9B Notes Offering and Strategic Moves

Updated Category News Views 59

A Look at AAR's Bold Move Big moves often come with big price tags, and AAR Corp's recent announcement is no exception. The aviation aftermarket titan recently declared a hefty $1.9 billion offering of senior notes, divided between 7.125% notes due 2031 and 7.375% notes maturing in 2034. It's a leap that signals their intent to snag a controlling interest in MRO Holdings,...

Continue Reading
Webull's China Ties Spark Investor Lawsuit: Act Now

Updated Category News Views 35

Trouble in Tech Paradise? Webull Faces Heat Look, when a tech name like Webull Corporation (NASDAQ: BULL) lands in the courtroom, it's enough to raise the eyebrows of anyone keeping tabs on their portfolio. So here's the deal: Webull's deep-rooted connection to China has come under fire, and boy, this ain't just another blip on the investor's radar. The company's...

Continue Reading
Wolfbox Unveils High-Octane Gear at SEMA 2026

Updated Category News Views 88

Revving Up with Wolfbox's New Offerings There's an electrifying hum in the air, buzz-fueled by Wolfbox's latest gear debut at the SEMA Show 2026 in Las Vegas. The booth is a treasure trove for anyone keen on amping up their vehicle tech, with Wolfbox laying bare everything from dazzling dash cams to adaptive trail lights. It's the kind of smorgasbord that'd make a...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 140

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
Watches of Switzerland Dazzles with Holiday Campaign

Updated Category News Views 84

Swiss Timepieces Take Center Stage Ever feel like there's a certain art to gift-giving? Apparently, The Watches of Switzerland Group thinks so, and they're not holding back in showing us how it's done with their new 'Brilliantly Given' campaign. They’re taking a classic approach by spotlighting luxury timepieces and fine jewelry just in time for the holiday...

Continue Reading
PATEO Drives In-Car AI Forward with NVIDIA Power

Updated Category News Views 0

Revolutionizing In-Vehicle AI with Big Names Boy, driving ain't what it used to be, and PATEO's latest adventure has a lot to do about it. They've hooked up with some major players like NVIDIA and ByteDance to really shake up the in-car AI scene. We're not just talking bells and whistles, but a true reinvention trying to blend AI straight into our daily grind on the road....

Continue Reading

Top 5 Most Recently Viewed Articles

Vicor Launches Innovative Power Modules for Automotive Needs

Updated Category News Views 323

Vicor Introduces Groundbreaking Automotive-Grade Power Modules Vicor has recently unveiled a trio of advanced automotive-grade power modules that promise unmatched power density, fostering the widespread adoption of 48V zonal architectures in vehicles. This innovative product line includes the BCM6135, DCM3735, and PRM3735, each designed to support 48V power distribution,...

Continue Reading
NACD Board Welcomes Industry Veterans to Strengthen Governance

Updated Category News Views 226

Leadership Changes at NACD Enhance Board Effectiveness Industry veterans bring a wealth of knowledge in governance and innovation. In a landmark move, the National Association of Corporate Directors (NACD) has strengthened its board with the appointments of Jesús Mantas and Wes Bricker. Both distinguished leaders are set to enhance the governance and strategic leadership...

Continue Reading
APLA Health Unveils Significant Growth at Long Beach Center

Updated Category News Views 138

APLA Health Celebrates a New Milestone Mayor Rex Richardson and Community Leaders Join Grand Reopening Celebration APLA Health is excited to announce the grand reopening of its Long Beach Health Center, following a significant expansion aimed at improving healthcare access for the LGBTQ+ community and other underserved populations. The expanded facility is a testament to...

Continue Reading
Apnimed's AD109 Phase 3 Trial Results Highlight Game-Changer

Updated Category News Views 347

Breakthrough in Obstructive Sleep Apnea Treatment with AD109 Apnimed, a clinical-stage pharmaceutical company, has recently made headlines with positive topline results from its second Phase 3 trial of AD109, known as LunAIRo. This trial has demonstrated substantial efficacy in addressing obstructive sleep apnea (OSA), reinforcing the potential of AD109 as the first oral...

Continue Reading
Castle Biosciences Faces Stock Decline Amidst New Challenges

Updated Category News Views 215

Castle Biosciences Stock Performance Overview Castle Biosciences, Inc. (NASDAQ: CSTL) has recently seen a notable decline in its stock price, falling 14% in a single day. This drop is primarily attributed to mixed reactions to the company’s preliminary performance and the implications of a recent ruling by a key payer. Although the firm announced that it expects to meet...

Continue Reading